The federal contract IDV awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services, to Glaxosmithkline, LLC aims to provide medical countermeasures such as vaccines and adjuvants to support pandemic preparedness and response efforts. The $4,687,707,199 single-award, indefinite-delivery, indefinite-quantity contract has a period of performance through February 2026 and does not utilize any set-aside designations.
Task orders under this IDV provide a range of services to the agency, including fill/finish activities for vaccine adjuvants, acquisition of influenza vaccine seed lots and bulk product, storage and stability testing of vaccine and adjuvant materials, and pandemic readiness efforts. The task orders are firm-fixed-price contracts, with ceiling values totaling over $150 million, to be performed primarily at Glaxosmithkline's facilities in North Carolina. This IDV and associated task orders support the government's broader initiatives to enhance public health preparedness and response capabilities for influenza and emerging disease outbreaks.
Generated 1/17/25, 9:04 AM